Immune checkpoint inhibitor-associated myocarditis and pericarditis: a pharmacovigilance study based on the FAERS database

Abstract Background Immune checkpoint inhibitors (ICIs) are medications used in cancer immunotherapy. However, treatment with ICIs may lead to adverse effects, particularly myocarditis and pericarditis. This practical pharmacovigilance study investigates the relationship between ICIs and myocarditis...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	Guojing Yao, Yu Zhang, Haixia Zhang, Linlin Tang, Chuanhua Ding, Xueheng Zhou
Format:	Article
Language:	English
Published:	BMC 2025-08-01
Subjects:	Immune checkpoint inhibitors (ICIs) Myocarditis/pericarditis Pharmacovigilance FDA adverse event reporting system (FAERS) Data mining
Online Access:	https://doi.org/10.1186/s12885-025-14668-x